INFORMATION INTENDED FOR PATIENTS

Epilepsy

Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. A number of patients who receive a diagnosis of epilepsy will have this diagnosis refined to a diagnosis of an epilepsy syndrome, which can be considerably more difficult to treat.

GW is committed to helping such patients and is researching new treatment options for conditions including Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis.